Evidence map›Paper›PMID 25158193›Full record

ArticleConnective tissue research2014

Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization.

Michael G Johnson, Jasmin Kristianto, Baozhi Yuan, Kathryn Konicke, Robert Blank

Abstract read
In one paragraph

Article in Connective tissue research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The -839(A/C) Polymorphism in theJournal of the Endocrine Society · 2019
    Article
  5. Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Article
  6. Article
  7. Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2017
    Review
  8. Endothelin Signaling in Bone.Endocrinology and metabolism clinics of North America · 2017
    Review
  9. Article
  10. Article
  11. Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.The Journal of clinical endocrinology and metabolism · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael G JohnsonDepartment of Medicine, Division of Endocrinology University of Wisconsin , Madison, WI , USA .
Jasmin Kristianto
Baozhi Yuan
Kathryn Konicke
Robert Blank
William S. Middleton Memorial Veterans Hospital · USMedical College of Wisconsin · USMilwaukee VA Medical Center · US

Funding

Congenic Mouse Strains Harboring Bone Strength Quantitative Trait LociR01AR054753 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI BLANK, ROBERT DANIEL · 2009 to 2013
$1.6M
NIAMS NIH HHS R01 AR054753
6 · The paper itself

Abstract

introductionEndothelin (ET1) promotes the growth of osteoblastic breast and prostate cancer metastases. Conversion of big ET1 to mature ET1, catalyzed primarily by endothelin converting enzyme 1 (ECE1), is necessary for ET1's biological activity. We previously identified the Ece1, locus as a positional candidate gene for a pleiotropic quantitative trait locus affecting femoral size, shape, mineralization, and biomechanical performance.

methodsWe exposed TMOb osteoblasts continuously to 25 ng/ml big ET1. Cells were grown for 6 days in growth medium and then switched to mineralization medium for an additional 15 days with or without big ET1, by which time the TMOb cells form mineralized nodules. We quantified mineralization by alizarin red staining and analyzed levels of miRNAs known to affect osteogenesis. Micro RNA 126-3p was identified by search as a potential regulator of sclerostin (SOST) translation.

resultsTMOb cells exposed to big ET1 showed greater mineralization than control cells. Big ET1 repressed miRNAs targeting transcripts of osteogenic proteins. Big ET1 increased expression of miRNAs that target transcripts of proteins that inhibit osteogenesis. Big ET1 increased expression of 126-3p 121-fold versus control. To begin to assess the effect of big ET1 on SOST production we analyzed both SOST transcription and protein production with and without the presence of big ET1 demonstrating that transcription and translation were uncoupled.

conclusionOur data show that big ET1 signaling promotes mineralization. Moreover, the results suggest that big ET1's osteogenic effects are potentially mediated through changes in miRNA expression, a previously unrecognized big ET1 osteogenic mechanism.

Indexed as

Bone Morphogenetic ProteinsCalcification, PhysiologicCell DifferentiationCells, CulturedEndothelin-1HumansMicroRNAsOsteoblastsOsteogenesisSignal TransductionBone Morphogenetic ProteinsEndothelin-1MicroRNAsAnabolic activitymineralizationosteoblastsosteogenesissignaling

Identifiers

PMID25158193
PMCPMC4640685
OpenAlexW1977923752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.